Generic placeholder image

Recent Patents on Cardiovascular Drug Discovery

Editor-in-Chief

ISSN (Print): 2212-3962
ISSN (Online): 1574-8901

Genotyping OLR1 Gene: A Genomic Biomarker for Cardiovascular Diseases

Author(s): Lucia Vecchione, Elisa Gargiul, Paola Borgiani, Irene Predazzi, Ruggiero Mango, Francesco Romeo, Mauro Magnani and Giuseppe Novelli

Volume 2, Issue 2, 2007

Page: [147 - 151] Pages: 5

DOI: 10.2174/157489007780832506

Price: $65

Abstract

The human lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), encoded by the OLR1 gene, is a scavenger receptor that has been implicated in the pathogenesis of atherosclerosis. LOX-1 activation is an important mechanism that contributes to plaque instability and subsequent development of acute coronary syndromes. Association studies have implicated OLR1 gene variants in myocardial infarction (MI) susceptibility. In particular, previously we demonstrated that intronic SNPs associated to susceptibility to myocardial infarction, regulate the expression of a new functional splicing isoform of the OLR1 gene, called LOXIN. The ratio OLR1/LOXIN mRNA is increased in subjects carrying the risk haplotype. On this basis, we developed a genetic kit named “LOXIN test” that allows the rapid identification of ORL1 genotypes and therefore establish the susceptibility risk to atherosclerosis and myocardial infarction. The recent patents related to OLR1, SNPs and LOXIN are also discussed in this article.

Keywords: LOX-1, LOXIN, OLR1, oxLDL, gene test, SNP, cardiovascular diseases, genomic biomarker


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy